Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NMNAT1 pseudogene 5 (NMNAT1P5) is a non-functional DNA sequence present in the human genome that shares significant homology with the functional NMNAT1 gene encoding nicotinamide mononucleotide adenylyltransferase 1, a key nuclear enzyme involved in NAD biosynthesis. Unlike the active NMNAT1 gene, NMNAT1P5 does not produce a protein or participate in biological pathways, nor is it implicated as a disease mediator, drug target, or biomarker. Pseudogenes for NMNAT1 are distributed on several chromosomes, including chromosomes 1, 3, 4, 14, and 15; NMNAT1P5 designates one of these pseudogenes—not the functional gene. The existence of NMNAT1P5, like other pseudogenes, is primarily a result of gene duplication or retrotransposition events; it has no known role in human physiology or disease. NMNAT1 pseudogene 5 (NMNAT1P5) is a non-coding pseudogene with no known biological, therapeutic, or clinical relevance. It is not considered a valid drug target, receptor, transporter, enzyme, or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NMNAT1 pseudogene 5 (NMNAT1P5).